BW – DEF 14A April 13, 2026 In SEC https://www.sec.gov/Archives/edgar/data/1630805/000110465926042128/0001104659-26-042128-index.htm #BW BW – DEFA14A Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria